Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Tetrabenazine 25 mg Tablets
NCT03696329Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Oct 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tetrabenazine in Huntington's disease (HD) (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area Under Curve at 24.00 hours. Started Oct 2015; status: completed.
02
Drugs
tetrabenazine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT03696329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696329.